Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General bacterial cellular components refers to the collective essential macromolecules of a bacterium—including genomic DNA, functional proteins, and structural membrane lipids—that are targeted by oxidative stress. This therapeutic approach relies on the generation of reactive oxygen species (ROS) or free radicals that cause non-specific, catastrophic damage to the cell (Imlay, J. A., 2013, Nature Reviews Microbiology). For instance, hydroxyl radicals can induce lipid peroxidation in the bacterial membrane and cause lethal double-strand breaks in genomic DNA (Vatansever, F., et al., 2013, FEMS Microbiology Reviews). Many antimicrobial agents, such as nitrofurantoin and metronidazole, act as prodrugs that are reduced by bacterial enzymes to form highly reactive intermediates that attack these components (StatPearls, 2023, Nitrofurantoin). Because the damage is distributed across multiple vital systems, it is significantly more difficult for bacteria to develop high-level resistance through single-point mutations compared to targeted antibiotics (Dwyer, D. J., et al., 2009, Current Opinion in Microbiology). However, the lack of inherent specificity means that these agents must often be targeted via localized application or selective metabolic activation to avoid damaging host cells (Lemire, J. A., et al., 2013, Nature Reviews Microbiology). This mechanism is a cornerstone of both antiseptic practice and the treatment of specific anaerobic or urinary tract infections.
Induction of non-specific oxidative damage via the generation of reactive oxygen species (ROS) or free radicals, leading to the destruction of bacterial DNA, proteins, and lipids.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General bacterial cellular components.